- Home
- Publications
- Publication Search
- Publication Details
Title
ISTH
guidelines for antithrombotic treatment in
COVID
‐19
Authors
Keywords
-
Journal
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-07-08
DOI
10.1111/jth.15808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
- (2022) Daniela Poli et al. Internal and Emergency Medicine
- Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically Ill Hospitalized Patients With COVID-19
- (2022) Jeffrey S. Berger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19
- (2022) David Tak Wai Lui et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
- (2022) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Good practice statements for antithrombotic therapy in the management of COVID ‐19: Guidance from the SSC of the ISTH
- (2022) Alex C. Spyropoulos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID ‐19: a propensity score‐matched analysis
- (2021) Matthew L. Meizlish et al. AMERICAN JOURNAL OF HEMATOLOGY
- The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19
- (2021) Lan Shen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients
- (2021) Stuart Lance Cohen et al. THROMBOSIS AND HAEMOSTASIS
- Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study
- (2021) Augusto Filippo Di Castelnuovo et al. THROMBOSIS AND HAEMOSTASIS
- Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration
- (2021) Thomas F. Osborne et al. PLoS One
- Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial
- (2021) Alejandro jose Gonzalez Ochoa et al. THROMBOSIS AND HAEMOSTASIS
- Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
- (2021) Christopher T Rentsch et al. BMJ-British Medical Journal
- Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intermediate vs Standard-dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to ICU: Ninety-day Results from the INSPIRATION Trial
- (2021) Behnood Bikdeli et al. THROMBOSIS AND HAEMOSTASIS
- Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
- (2021) Dimitrios Giannis et al. BLOOD
- Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: A multi‐center, open‐label, randomized controlled trial
- (2021) Usha S. Perepu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
- (2021) Renato D Lopes et al. LANCET
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Low molecular weight heparin is useful in adult COVID-19 inpatients. Experience during the first Spanish wave: observational study
- (2021) Jose Ramon Gonzalez-Porras et al. Sao Paulo Medical Journal
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
- (2021) Dawn O. Kleindorfer et al. STROKE
- Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
- (2021) José Miguel Rivera-Caravaca et al. THROMBOSIS RESEARCH
- Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study
- (2021) David Pereyra et al. CARDIOVASCULAR RESEARCH
- Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19
- (2021) Jean M. Connors et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study
- (2021) et al. Journal of Hematology & Oncology
- Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
- (2021) Eduardo Ramacciotti et al. LANCET
- Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
- (2021) Michelle Sholzberg et al. BMJ-British Medical Journal
- Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
- (2021) Alex C. Spyropoulos et al. JAMA Internal Medicine
- Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study
- (2021) David M. Smadja et al. Frontiers in Medicine
- The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study
- (2021) Husam Abdel-Qadir et al. THROMBOSIS RESEARCH
- Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
- (2020) Alex C. Spyropoulos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
- (2020) Alex C. Spyropoulos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Anticoagulation Dose and Survival in Hospitalized COVID‐19 Patients: A Retrospective Propensity Score Weighted Analysis
- (2020) Filip Ionescu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Direct oral anticoagulant use and risk of severe COVID‐19
- (2020) B. Flam et al. JOURNAL OF INTERNAL MEDICINE
- Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
- (2020) Anna Cristina Bertoldi Lemos et al. THROMBOSIS RESEARCH
- Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
- (2015) S. Kaatz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ACCF/AHA Clinical Practice Guideline Methodology Summit Report
- (2012) Alice K. Jacobs et al. CIRCULATION
- Dalteparin versus Unfractionated Heparin in Critically Ill Patients
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
- (2010) S. BARBAR et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started